Our Story

Advancing Healing with the Gift of Humanity!

Transforming the Body’s Innate Healing Potential into the Future of Medicine

ECM Biomedical was born from a scientist’s profound belief in the power of life.

Our founder, Dr. Yi-Yang Tsai, devoted years of research in the United States to the fields of human tissue and regenerative medicine. Through this experience, he came to understand that the human body is more than a collection of cells and organs—it possesses a sophisticated, continuously functioning system of self-repair.

He has always believed that life’s greatest strength lies in its inherent capacity to repair and renew itself. The true value of regenerative medicine is not to replace the human body, but to preserve and harness its natural healing potential through science and technology.

Guided by this vision, Dr. Tsai returned to Taiwan and founded ECM Biomedical in 2022. His goal was to introduce internationally developed human tissue regeneration technologies into clinical practice, transforming regenerative medicine from laboratory research into a meaningful resource for physicians and creating new opportunities for tissue repair and reconstruction.

ECM Biomedical specializes in the research, development, and manufacturing of human tissue-based regenerative materials, including human amniotic membrane, acellular dermal matrix, and demineralized bone matrix (DBM). Beginning with lawful and rigorous donor tissue sourcing and management, we integrate innovative processing technologies, comprehensive quality systems, and scientific validation to preserve the natural properties of human tissues and deliver regenerative medical products with safety and clinical value.

The name ECM Biomedical is derived from the term “extracellular matrix,” or ECM. The extracellular matrix not only provides structural support for human tissues but also creates an essential microenvironment for cellular growth, repair, and reconstruction. This concept embodies our philosophy: rather than replacing the human body, we strive to create an environment that supports healing and enables the body to realize its inherent regenerative potential.

Within just a few years, ECM Biomedical has established a comprehensive human tissue regeneration platform encompassing human amniotic membrane, acellular dermal matrix, and demineralized bone matrix. We continue to invest in innovative technologies and collaborate closely with clinical professionals to advance regenerative medicine, bring renewed hope to more patients, and introduce Taiwan’s human tissue technologies to the global medical community.

We believe that the best medicine does not replace life—it awakens the healing power already within it.

Advancing Healing with the Gift of Humanity!